These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29718020)

  • 21. Moderate to severe hidradenitis suppurativa treated with biological therapies.
    Chinniah N; Cains GD
    Australas J Dermatol; 2014 May; 55(2):128-31. PubMed ID: 24456051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of interleukin-17 in the pathogenesis of hidradenitis suppurativa.
    Yao Y; Thomsen SF
    Dermatol Online J; 2017 Jul; 23(7):. PubMed ID: 29469692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of patients with hidradenitis suppurativa.
    Martorell A; Caballero A; González Lama Y; Jiménez-Gallo D; Lázaro Serrano M; Miranda J; Pascual JC; Salgado-Boquete L; Marín-Jiménez I
    Actas Dermosifiliogr; 2016 Sep; 107 Suppl 2():32-42. PubMed ID: 28081768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Systemic treatment of moderate/severe hidradenitis suppurativa].
    Pinter A; Mrowietz U; Volz T
    Hautarzt; 2021 Aug; 72(8):686-691. PubMed ID: 34189590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenesis and pharmacotherapy of Hidradenitis suppurativa.
    Nazary M; van der Zee HH; Prens EP; Folkerts G; Boer J
    Eur J Pharmacol; 2011 Dec; 672(1-3):1-8. PubMed ID: 21930119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of hidradenitis suppurativa in pregnancy.
    Perng P; Zampella JG; Okoye GA
    J Am Acad Dermatol; 2017 May; 76(5):979-989. PubMed ID: 28040373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Open-label, investigator-initiated, single-site exploratory trial evaluating secukinumab, an anti-interleukin-17A monoclonal antibody, for patients with moderate-to-severe hidradenitis suppurativa.
    Prussick L; Rothstein B; Joshipura D; Saraiya A; Turkowski Y; Abdat R; Alomran A; Zancanaro P; Kachuk C; Dumont N; Gottlieb AB; Rosmarin D
    Br J Dermatol; 2019 Sep; 181(3):609-611. PubMed ID: 30801662
    [No Abstract]   [Full Text] [Related]  

  • 28. Local wound care and topical management of hidradenitis suppurativa.
    Alavi A; Kirsner RS
    J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S55-61. PubMed ID: 26470618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug survival of biologics in hidradenitis suppurativa: A systematic review and meta-analysis.
    Pham JP; Rosenø NAL; Roccuzzo G; Saal RC; Egeberg A; Ring HC; Frew JW
    J Am Acad Dermatol; 2024 Jul; 91(1):170-172. PubMed ID: 38554939
    [No Abstract]   [Full Text] [Related]  

  • 30. A Retrospective Cohort Study on Patients with Hidradenitis Suppurativa.
    Seyed Jafari SM; Knüsel E; Cazzaniga S; Hunger RE
    Dermatology; 2018; 234(1-2):71-78. PubMed ID: 29758553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medical management of hidradenitis suppurativa.
    Orenstein LA; Micheletti RG
    Semin Cutan Med Surg; 2017 Jun; 36(2):62-66. PubMed ID: 28538746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammatory Mechanisms in Hidradenitis Suppurativa.
    Kelly G; Prens EP
    Dermatol Clin; 2016 Jan; 34(1):51-8. PubMed ID: 26617358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bacteriology of hidradenitis suppurativa/acne inversa: A review.
    Nikolakis G; Join-Lambert O; Karagiannidis I; Guet-Revillet H; Zouboulis CC; Nassif A
    J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S12-8. PubMed ID: 26470608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hidradenitis suppurativa and Crohn's disease: two cases that support an association.
    Yazdanyar S; Miller IM; Jemec GB
    Acta Dermatovenerol Alp Pannonica Adriat; 2010 Oct; 19(3):23-5. PubMed ID: 20976417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recalcitrant severe hidradenitis suppurativa successfully treated with cyclosporine A.
    Bianchi L; Hansel K; Stingeni L
    J Am Acad Dermatol; 2012 Dec; 67(6):e278-9. PubMed ID: 23158638
    [No Abstract]   [Full Text] [Related]  

  • 36. Canakinumab for Severe Hidradenitis Suppurativa: Preliminary Experience in 2 Cases.
    Houriet C; Seyed Jafari SM; Thomi R; Schlapbach C; Borradori L; Yawalkar N; Hunger RE
    JAMA Dermatol; 2017 Nov; 153(11):1195-1197. PubMed ID: 28854317
    [No Abstract]   [Full Text] [Related]  

  • 37. Successful use of guselkumab in the treatment of severe hidradenitis suppurativa.
    Kearney N; Byrne N; Kirby B; Hughes R
    Clin Exp Dermatol; 2020 Jul; 45(5):618-619. PubMed ID: 32068912
    [No Abstract]   [Full Text] [Related]  

  • 38. Pain management in patients with hidradenitis suppurativa.
    Horváth B; Janse IC; Sibbald GR
    J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S47-51. PubMed ID: 26470616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful treatment of severe hidradenitis suppurativa with anakinra.
    Zarchi K; Dufour DN; Jemec GB
    JAMA Dermatol; 2013 Oct; 149(10):1192-4. PubMed ID: 23966107
    [No Abstract]   [Full Text] [Related]  

  • 40. Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients.
    Gener G; Canoui-Poitrine F; Revuz JE; Faye O; Poli F; Gabison G; Pouget F; Viallette C; Wolkenstein P; Bastuji-Garin S
    Dermatology; 2009; 219(2):148-54. PubMed ID: 19590173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.